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Abstract
Background: We recently reported the derivation of a diagnostic aid to rule out pneumonia in adults presenting
with new onset of cough or worsening of chronic cough and increased body temperature. The aim of the present
investigation was to validate the diagnostic aid in a new sample of primary care patients.
Methods: From two group practices in Zurich, we included 110 patients with the main symptoms of cough and
subjective feeling of increased body temperature, and C-reactive protein levels below 50 μg/ml, no dyspnea, and
not daily feeling of increased body temperature since the onset of cough. We excluded patients who were
prescribed antibiotics at their first consultation. Approximately two weeks after inclusion, practice assistants
contacted the participants by phone and asked four questions regarding the course of their complaints. In
particular, they asked whether a prescription of antibiotics or hospitalization had been necessary within the last two
weeks.
Results: In 107 of 110 patients, pneumonia could be ruled out with a high degree of certainty, and no prescription
of antibiotics was necessary. Three patients were prescribed antibiotics between the time of inclusion in the study
and the phone interview two weeks later. Acute rhinosinusitis was diagnosed in one patient, and antibiotics were
prescribed to the other two patients because their symptoms had worsened and their CRP levels increased. Use of
the diagnostic aid could have missed these two possible cases of pneumonia. These observations correspond to a
false negative rate of 1.8% (95% confidence interval: 0.50%-6.4%).
Conclusions: This diagnostic aid is helpful to rule out pneumonia in patients from a primary care setting. After
further validation application of this aid in daily practice may help to reduce the prescription rate of unnecessary
antibiotics in patients with respiratory tract infections.
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Background
The inappropriate prescription of antibiotics is an avoid-
able cause of the increasing problem of antibiotic resist-
ance. Overuse of antibiotics for upper respiratory tract
infections is common, although guidelines recommend
antibiotics only for patients with bacterial pneumonia or
moderate to severe exacerbations of chronic bronchitis
[1-4]. However, in a recent publication also a benefit of
antibiotic treatment has been demonstrated in patients
with mild to moderate exacerbations [5]. Physicians are
aware of the recommendations in the guidelines, but
they may have understandable concerns about missing
pneumonia in patients with cough and increased body
temperature, and when in doubt, physicians prefer to
prescribe antibiotics.
In a recently published study [6] we reported the der-
ivation of a fast and low-cost diagnostic aid to rule out
pneumonia in patients with new onset of cough or wor-
sening of chronic cough and the subjective feeling of
increased body temperature. A total of 621 patients, al-
most all of them attending a primary care physician were
included in the derivation study. The mean age of that
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patients was 48 years and half of them were males. The
derivation study showed that three pieces of information
are necessary to rule out pneumonia in these patients;
C-reactive protein (CRP) level, dyspnea (no/yes), and
daily feeling of increased body temperature since onset
of cough (no/yes). Pneumonia could be ruled out in
patients with CRP levels below 50 μg/ml who lacked
dyspnea and daily subjective feeling of increased body
temperature since onset of cough. At the time of publi-
cation, this diagnostic aid had not been validated in
patients outside of the derivation sample.
Before integrating such a diagnostic aid into daily prac-
tice, the accuracy of the instrument should be tested in a
new sample of patients.. The aim of this study is to evaluate
the accuracy of the diagnostic aid in patients with CRP
levels below 50 μg/ml, no dyspnea and not daily subjective
feeling of increased body temperature since onset of cough.
Methods
The ethics committee of the Canton Zurich approved
the study protocol, and we obtained informed consent
from all participants.
Recruitment of physicians
Physicians from two group practices in Zurich (mediX
group practice and “Praxisgemeinschaft Altstetten,” both
located in the urban Zurich area) were invited to partici-
pate in this study. They were provided with detailed in-
formation about the study, including the questionnaire
for patient histories and the patient information leaflet.
In- and exclusion criteria
Patients aged 16 years or older with the main symptom
of new or worsened cough lasting at least 24 hours and
who experienced the feeling of increased body
temperature were potentially eligible for this study. Only
patients in which our decision aid was negative, meaning
patients with CRP levels less than 50 μg/ml (normal <
10 μg/ml), no dyspnea reported by the patient, no daily
subjective feeling of increased body temperature since
the onset of cough, and no treatment with antibiotics
after the first consultation. We excluded patients with
known chronic lung diseases (except chronic bronchitis),
HIV-positive patients, patients who had taken oral corti-
costeroids within the last month, patients on chemother-
apy, patients after organ transplantation, pregnant
women, and patients incapable of reading the informa-
tion leaflet and/or providing informed consent. Patients
who were prescribed antibiotics at the initial consult-
ation were excluded from the validation sample [7].
Data gathering
Physicians assessed medical history after obtaining
informed consent from the eligible patients. In particular,
they asked patients about the presence of dyspnea and the
duration and regularity (daily or not) subjective feeling of
increased body temperature. Body temperature was not
measured during consultation and patients were not
instructed to measure body temperature at home. Venous
blood samples for measuring CRP levels were drawn from
all patients, and blood was analyzed using standard proce-
dures. Other diagnostic procedures, treatment type, and
the decision to initiate antimicrobial treatment were left
to the discretion of the treating physician.
At a minimum of one week after the first consultation
(inclusion of patients), physicians or physician assistants
contacted the patients for follow-up only once by phone
or during a planned office consultation. All patients
were asked four questions: Have you received a prescrip-
tion for antibiotics since the time of the consultation
leading to inclusion in the study? Have you been hospi-
talized during this time? Has the severity of your cough
decreased, increased, or remained stable since the first
consultation? Has the subjective feeling of increased
body temperature disappeared, remained stable, or wor-
sened? When a patient had been hospitalized since in-
clusion in the study, we contacted hospitals to obtain
the information whether pneumonia or another illness
was the reason for the hospitalization.
When patients at the follow-up consultation (by phone
or in the office) reported that symptoms improved and
no antibiotics had been prescribed to them since the
first consultation we assumed that a clinically relevant
pneumonia could be excluded with a high degree of
certainty.
Statistical analysis
The sample size of this study was planned to estimate the
proportion of falsely classified non-pneumonia cases with
a specified precision. For this we assumed p to be 2% (p =
0.02), and the standard error (p) = 0.015 such that the
upper bound of the 95% confidence interval for p does
not exceed 5%. These specifications led to a sample size of
n = 88; we aimed to include at least 90 patients.
All patients fulfilling the inclusion criteria, and with
complete answers to the four interview questions, were
included in the statistical analysis. Descriptive statistics
were calculated for patient demographic information,
clinical signs of disease, and answers to the four inter-
view questions. Categorical variables were displayed as
percentages, and continuous variables as median and
range. For the estimation of the proportion of falsely
classified non-pneumonia cases p^ , we determined the
number of patients who received an antibiotics prescrip-
tion for the diagnosis of pneumonia (question 1), and
divided that number by n. We estimated the correspond-
ing 95% confidence interval with the Wilson score inter-
val [8]. All analyses were performed with R 2.14 [9].
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Results
Between December 2011 and May 2012, 115 patients
were eligible for this study. Five patients who fulfilled
the inclusion criteria were excluded because antibiotics
had been prescribed during the first consultation. There-
fore, 110 patients remained in the study for statistical
analysis. To obtain information about the proportion of
patients with cough and increased body temperature ful-
fill the inclusion criteria, the practice assistants regis-
tered all potentially eligible patients with cough and
feeling of increased body temperature during two weeks
in January 2012. Within those two weeks, the practice
assistants counted 34 potentially eligible patients; ten of
these patients, a bit less than a third, were eligible for in-
clusion in the study.
The median age of the included patients was 39 years
(range 16 to 86 years), and 73 (66%) were female. The me-
dian duration between new onset and worsening of
chronic cough was 7 days (interquartile range 4 to 14)
days. The median CRP level was 6.3 μg/ml (range 1 to
44 μg/l), 61% of the included patients had a CRP level
below 10 μg/l, and 39% of participants had a CRP level be-
tween 11 μg/l and 50 μg/l. In two patients, chest x-rays at
the time of the first consultation showed no pathological
changes. Detailed information about included patients is
shown in Table 1.
All 110 patients enrolled in the study were contacted a
median of 13 days (interquartile range 11 to 15 days)
after enrollment in the study. Cough had improved in 90
(81.8%) of participants, had worsened in 6 (5.5%), and
had remained stable in 11 (10%) of patients. Subjective
feeling of increased body temperature disappeared com-
pletely in 98% of the patients, and two patients reported
that they still had intermittent increased measured body
temperature. In none of the patients a chest x-ray was
performed after the first visit.
Three patients received a prescription for antibiotics
between the time of inclusion in the study and the
phone call by the practice assistant. For one patient with
an increase of fever, deterioration of general health sta-
tus, and an increase in CRP levels from 40 to 60 μg/ml
two days after the first consultation, antibiotic treatment
had been prescribed without an evaluative chest x-ray.
In the second patient antibiotic treatment had been pre-
scribed due to worsening of her cough and an increase
in CRP level from 14 μg/ml to 67 μg/ml. No chest x-ray
had been performed for this patient either. In the third
patient a diagnosis of acute purulent rhinosinusitis was
established three days after the first consultation, and
treatment with antibiotics was initiated.
In 107 out of 110 patients, pneumonia could be ruled
out with a very high degree of certainty. In the
remaining three patients, who received antibiotics after
inclusion, we did not miss an apparent case of pneumo-
nia; there could have been one or two potential cases of
pneumonia, but it is unlikely. Based on these data, the
maximum proportion of missed pneumonia cases is p^ ¼
2=110 ¼ 0:018 (95% confidence interval 0.005-0.064) as
a worst-case scenario.
Discussion
Main results
We validated a simple diagnostic aid for ruling out pneumo-
nia in patients with cough and increased body temperature
[5] in a new primary care population. In patients with
cough, feeling of increased body temperature, and a CRP
level below 50 μg/ml, but without dyspnea and daily
subjective feeling of increased body temperature since
the onset of cough, pneumonia can be ruled out safely as
the underlying illness. The predictive performance of the
simple diagnostic aid was good, as no definite case of pneu-
monia was missed and only two potential cases of pneumo-
nia appeared. If we rate both these cases as patients with
missed pneumonia – the worst-case scenario − then the
estimated proportion of falsely classified non-pneumonia
cases is 1.8%.
Limitations of the study
Patients included in this study represented approxi-
mately one-third of the patients attending general practi-
tioners because of cough and subjective feeling of
increased body temperature. The fact that no chest x-
rays, the reference test, were performed in these patients
may be seen as a limitation of this study [7]. It would
not have been possible to obtain approval from the
Table 1 Baseline characteristics of 110 patients included
in the study
Variable Statistic used n = 110
Baseline
Age (years) Median 39
Range 16 - 86
IQR 16.25
Gender Male 37 (33.6%)
Female 73 (66.4%)
Cough (since . . . days) Median 7
Range 2 - 75
IQR 10
Chronic cough (> 4 weeks) 6 (5.5%)
CRP [μg/ml] Median 6.3
Range 0 - 44
IQR 16.1
Chest x-ray Yes 2 (1.8%)
No 108 (98.2%)
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ethics committee to perform a chest x-ray in all patients.
We therefore chose a pragmatic alternative to rule out
“clinically relevant” pneumonia with a high degree of cer-
tainty by contacting patients approximately two weeks after
the first consultation to ask them about the course of
cough and subjective feeling of increased body temperature,
prescription of antibiotics, and hospitalization. We cannot
guarantee that we have not missed patients with pulmonary
infiltrates that are consistent with pneumonia, but the
probability that patients with moderate or severe pneumo-
nia were missed is almost zero.
A further weakness of our study is that patients were
probably not enrolled consecutively. We are not sure
that all eligible patients with cough and increased body
temperature were included in this study. The median
duration of cough was one week, comparable to the dur-
ation of cough in the population of the derivation study
[6]. This observation indicates that physicians may have
preferentially included patients with longer duration of
symptoms and, likely, a higher suspicion of pneumonia.
Clinical implications
When physicians, after taking the patient history and
performing the physical exam, are in doubt whether
pneumonia could be present and therefore prescribe
antibiotic treatment, the validated diagnostic aid is use-
ful for two reasons. In patients with CRP levels below
50 μg/ml, no dyspnea, and no daily subjective feeling of
increased body temperature since the onset of cough,
pneumonia is very unlikely at the time of consultation.
Unnecessary chest x-rays as well as unnecessary pre-
scriptions of antibiotics can be avoided. However, symp-
toms could worsen in the days following the first
consultation, making further tests and antibiotic treat-
ment necessary.
Applying this diagnostic aid in daily practice may lead
to a reduction in the overuse of antibiotics as well as a
reduction in associated problems caused by this overuse.
In our previous derivation study [7], we demonstrated
that use of the simple diagnostic aid would have led to a
decrease in antibiotic prescriptions of approximately ten
percent even in a population of patients with a low risk
of pneumonia. Acute respiratory tract infections are the
most common reason for inappropriate antibiotic ther-
apy in primary care. In view of the increasing problem
of antibiotic resistance, possible side effects, and costs,
even a small reduction is desirable and will impact pub-
lic health.
Implications for further research
In the future, the diagnostic aid should be validated in
additional patient populations and in various health care
settings. These validations will increase the reliability of
this simple diagnostic instrument, and motivate physi-
cians to apply it to their daily practice.
Conclusion
Validation of the diagnostic aid in a new sample of pri-
mary care patients revealed that the instrument is highly
accurate at ruling out pneumonia in patients with cough
and subjective feeling of increased body temperature.
The application of this rapid and low-cost instrument
may support a change in physician behavior, reducing
the rate of unnecessary chest x-rays and antibiotic pre-
scriptions in patients with low risk of pneumonia. These
improvements would markedly contribute to cost con-
trol and address the increasing problem of antibiotic
resistance.
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